Skip to main content

Year: 2026

Workhorse Group Reports Fourth Quarter and Full Year 2025 Results

Revenue of $9.7 million in Q4 2025, up 64% year-over-year; full year revenue of $21.2 million, up 201% year-over-year On a pro forma basis, combined company revenue of $34.0 million for full year 2025, compared to $13.7 million in 2024, an increase of 149% Delivered 65 vehicles in Q4 2025 and 112 vehicles for full year 2025, compared to 46 vehicles in full year 2024 Combined delivered trucks surpassed 20 million real-world miles across more than 1,100 deployed vehicles Targeting $20 million in annualized cost synergies from merger integration as the company exits 2026 Announced a 140 kWh battery configuration of W56 step van in response to customer demandDETROIT, March 31, 2026 (GLOBE NEWSWIRE) — Workhorse Group Inc. (NASDAQ: WKHS) (“Workhorse” or the “Company”), a North American OEM and provider of all-electric trucks, step...

Continue reading

Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights

ZYCUBO® approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Therapeutics sold its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $205 million; Cyprium is also eligible to receive tiered royalties and up to approximately $128 million in aggregate sales milestones from Sentynl Therapeutics Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress remains eligible to receive up to an additional $4.8 million under a contingent value right (CVR), plus a 2.5% royalty on net sales of UNLOXCYT™ (cosibelimab-ipdl) MIAMI, March 31, 2026 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue,...

Continue reading

Birchtech Reports Fourth Quarter 2025 Financial Results

Fourth Quarter Product Revenues Grew 19.8% Year-over-Year and Net Loss Improved by $0.8 Million; Collection Activities on $78 Million Final Judgement Underway CORSICANA, Texas, March 31, 2026 (GLOBE NEWSWIRE) — Birchtech Corp. (NYSE American: BCHT) (TSX: BCHT) (“Birchtech” or the “Company”), a leader in specialty activated carbon technologies for sustainable air and water treatment, today reported financial results for the fourth quarter and full year ended December 31, 2025. Key Fourth Quarter 2025 & Subsequent Operational HighlightsSuccessfully uplisted to the NYSE American in February 2026 with a concurrent public offering raising aggregate gross proceeds of approximately $16.6 million, including the partial exercise of the underwriters’ over-allotment option, significantly strengthening the Company’s balance...

Continue reading

BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Initiated a formal process to monetize assets  Implemented a restructuring plan to significantly reduce operating expenses and extend runwaySAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced its financial results for the full year and fourth quarter ended December 31, 2025 and provided business highlights. “As we evaluate strategic paths forward, our focus remains on supporting the advancement of the ongoing Phase 1 study of BA3182 in adenocarcinomas, while preserving capital, and ensuring we maintain the flexibility to pursue all potential value‑creating options,” said Jay M. Short, Ph.D., Chairman, Chief Executive Officer...

Continue reading

Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

— Enrollment underway in FDA-authorized FINALE pivotal trial demonstrating execution toward FemBloc® U.S. approval — ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the year ended December 31, 2025 and provides a corporate update. Corporate Highlights from 4Q 2025 to dateInitiated patient enrollment in the FINALE pivotal clinical trial evaluating FemBloc, advancing toward U.S. approval. Appointed Kenneth D. Eichenbaum, M.D., M.S.E., to the Board of Directors, strengthening leadership and strategic oversight. FemBloc permanent birth control system achieved certification under the Medical Device Single Audit Program...

Continue reading

Sportsman’s Warehouse Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Full year same store sales growth of 1%Decreased inventory by $29.1 million or 8.5%; reduced net debt by 6.1%Provides full year 2026 outlook WEST JORDAN, Utah, March 31, 2026 (GLOBE NEWSWIRE) — Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s Warehouse” or the “Company”) (Nasdaq: SPWH) today announced financial results for the thirteen and fifty-two weeks ended January 31, 2026. “We are pleased with our improved fourth quarter finish and full-year performance, which exceeded our revised guidance following our third quarter of 2025, and reflects the meaningful progress we are making against our strategic initiatives,” said Paul Stone, Chief Executive Officer of Sportsman’s Warehouse. “In 2025, we returned to positive same store sales growth for the first time since 2020, while also strengthening our balance sheet, improving...

Continue reading

Old National Bancorp Announces Schedule for First-Quarter Earnings Release and Conference Call

EVANSVILLE, Ind., March 31, 2026 (GLOBE NEWSWIRE) — (NASDAQ: ONB) – Old National Bancorp (“Old National”), the holding company of Old National Bank, today announced the following schedule for its first-quarter earnings release and conference call: Earnings Release:  Wednesday, April 22, 2026, at approximately 7:00 A.M. ET Conference Call:    Wednesday, April 22, 2026, at 10:00 A.M. ET Dial-in Numbers:    U.S. (800) 715-9871; International: (646) 307-1963; Access code 9394540 Webcast:                 Via Old National’s Investor Relations website at oldnational.com Webcast Replay:    Available approximately one hour after completion of the call, until midnight ET on April 22, 2027, via Old National’s Investor Relations website at oldnational.com Telephone Replay: U.S. (800) 770-2030; International: (609) 800-9909; Access code 9394540....

Continue reading

Investview, Inc. (“INVU”) Reports Full Year 2025 Financial Results, Operational Highlights, and a Year-End Message from the CEO

Company Adopts Strategic Initiatives Designed to Position Itself for Growth During 2026  Haverford, PA, March 31, 2026 (GLOBE NEWSWIRE) — Investview, Inc. (OTCQB: INVU) operates a diversified series of business units across key sectors, including a direct-to-consumer (“DTC”) marketing platform designed to promote, sell, and distribute its products and services through a global network of independent distributors directly to end users without reliance on traditional retail intermediaries; a manufacturing, marketing, and sales division focused on proprietary over-the-counter aesthetics, health, nutrition and cognitive wellness products for distribution across wholesale and retail markets through our DTC marketing platform and otherwise; an early-stage online trading platform that intends to offer self-directed retail brokerage services;...

Continue reading

C-IV Capital Partners to Acquire Greystone’s Special Servicing Business

DALLAS and NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) — Greystone Servicing Company LLC (“Greystone”) and C-IV Capital Partners LLC (“C-IV”) today announced that they have entered into a definitive agreement pursuant to which C-IV has agreed to acquire Greystone’s commercial real estate loan special serving business. The closing of the transaction is subject to customary conditions and is expected to occur in the second or third quarter of 2026. Financial terms of the transaction were not disclosed. About Greystone Greystone is a private national commercial real estate finance company with an established reputation as a leader in multifamily and healthcare finance, having ranked as a top FHA, Fannie Mae, and Freddie Mac lender in these sectors. Loans are offered through Greystone Servicing Company LLC, Greystone Funding Company LLC...

Continue reading

WORLDLINE : Results of the rights issue – Press release

Not for release, publication or distribution, directly or indirectly, in or into Canada, Australia, Japan or South Africa. Worldline announces the success of its share capital increase with preferential subscription rights for an amount of c. €392 million as part of its c. €500 million capital raise Paris, La Défense, 31 March 2026 – Worldline S.A. [ISIN: FR0011981968 – Euronext: WLN] (the “Company” or “Worldline”), a European leader in payment services, announces today the success of its c. €392 million share capital increase with preferential subscription rights (the “Rights Issue”) announced on 12 March 2026. Results of the Rights Issue The gross proceeds of the Rights Issue amount to €391,780,753.76 (including issue premium) through the issuance of 1,939,508,682 new shares of the Company (the “New Shares”) at a subscription price...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.